Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

IVIG for Drug and Device Refractory Gastrointestinal Auto-Immune Neuropathy

NCT04208828 is registered in ClinicalTrials.gov with University of Louisville as lead sponsor.

NCT NCT04208828
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04208828 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
IVIG for Drug and Device Refractory Gastrointestinal Auto-Immune Neuropathy
Lead sponsor
University of Louisville
Phase
Observational
Overall status
Recruiting
Start date
January 2, 2020
Completion date
January 2, 2028
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastrointestinal motility disorder, gastroparesis, neuropathy